Backstory of: A randomized, double-blind phase 2 clinical trial of blosozumab, a sclerostin antibody, in postmenopausal women with low bone mineral density
- Backstories,
- Robert Recker
Backstories
Backstories
Corresponding Author:josh+backstories@authorea.com
Author Profile
